Featured Articles

Antigenics Begins 120-Patient Phase...

Business Editors/Health/Medical Writers BIOWIRE2K NEW YORK--(BUSINESS WIRE)--April 9, 2003 Antigenics Inc. (NASDAQ...

Dariers Disease - Prevention Tips a...

Dariers Disease - Prevention Tips and Treatment Methods Darier disease is also known as ‘keratosis follic...

Indonesia's Antara news agency gets...

JAKARTA, Dec. 13 Kyodo Budiarto Danujaya will replace Parni Hadi as chief editor of Indonesia's state-run news agenc...

Optimizing ADHD therapy with sustai...

Attention deficit hyperactivity disorder (ADHD) is a pr-edominantly childhood disorder characterized by inattention, ...

Clinical experience results with cl...

Abstract

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

Drug Information Related to Patanase Nasal Spray

Back

01. invivodata's DiaryPRO Captures Primary Efficacy Data for PATANASE Nasa...

Alcon Receives FDA Approval to Market PATANASE in U.S. PITTSBURGH -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that its eDiary solution, DiaryPRO([R]...

02. Alcon's PATANASE® Nasal Spray Approved by FDA for Treatment of Nasal ...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE: ACL) announced today that the U.S. Food and Drug Administration (FDA) has approved PATANASE([R]) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of ...

03. invivodata's DiaryPRO Captures Primary Efficacy Data for PATANASE Nasa...

Alcon Receives FDA Approval to Market PATANASE in U.S. ...